These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3138042)

  • 21. Quantitative measurement of lipoprotein particles containing both apolipoprotein AIV and apolipoprotein B in human plasma by a noncompetitive ELISA.
    Ferrer F; Bigot-Corbel E; N'Guyen P; Krempf M; Bard JM
    Clin Chem; 2002 Jun; 48(6 Pt 1):884-90. PubMed ID: 12029004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates.
    Brinton EA; Eisenberg S; Breslow JL
    J Clin Invest; 1990 Jan; 85(1):144-51. PubMed ID: 2104877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of two monoclonal antibodies to human apolipoprotein A-I that also bind to rabbit apolipoprotein A-I. Application to ELISA evaluation of rabbit serum apo A-I.
    Leroy A; Olivier P; Vu-Dac N; Fruchart JC
    Clin Chim Acta; 1989 Jan; 179(1):85-95. PubMed ID: 2493349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The determination of apolipoproteins Apo A-I and Apo B. A comparative study of methods].
    Keller H; Riesen WF
    Z Med Lab Diagn; 1990; 31(4):200-10. PubMed ID: 2116698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increase of plasma proapolipoprotein A-I in patients with liver cirrhosis and its relationship to circulating high-density lipoproteins 2 and 3.
    Suehiro T; Yamamoto M; Yoshida K; Ohno F
    Clin Chem; 1993 Jan; 39(1):60-5. PubMed ID: 8419059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urine concentrations of apolipoprotein AI in renal tubular proteinuria.
    Reichl D; Beetham R
    Metabolism; 1988 May; 37(5):422-4. PubMed ID: 3130543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative determination of human plasma apolipoprotein A-I by laser immunonephelometry.
    Rosseneu M; Vercaemst R; Vinaimont N; Van Tornout P; Henderson LO; Herbert PN
    Clin Chem; 1981 Jun; 27(6):856-9. PubMed ID: 6786798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anomalies in composition of uremic lipoproteins isolated by gradient ultracentrifugation: relative enrichment of HDL in apolipoprotein C-III at the expense of apolipoprotein A-I.
    Atger V; Duval F; Frommherz K; Drüeke T; Lacour B
    Atherosclerosis; 1988 Nov; 74(1-2):75-83. PubMed ID: 3145749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms responsible for increasing immunoreactivity of apolipoprotein A-I with storage: the role of oxidation.
    Wang XL; Dudman NP; Wang J; Wilcken DE
    Clin Chem; 1989 Oct; 35(10):2082-6. PubMed ID: 2507198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum apolipoprotein A-II, a biochemical indicator of alcohol abuse.
    Puchois P; Fontan M; Gentilini JL; Gelez P; Fruchart JC
    Clin Chim Acta; 1984 Dec; 144(2-3):185-9. PubMed ID: 6152204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in serum apolipoprotein and lipoprotein profile induced by chronic alcohol consumption and withdrawal: determinant effect on heart disease?
    Lecomte E; Herbeth B; Paille F; Steinmetz J; Artur Y; Siest G
    Clin Chem; 1996 Oct; 42(10):1666-75. PubMed ID: 8855152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of a monoclonal antibody that binds to apolipoprotein E and to lipoprotein of human plasma containing apo E. Applications to ELISA quantification of plasma apo E.
    Leroy A; Vu-dac N; Koffigan M; Clavey V; Fruchart JC
    J Immunoassay; 1988; 9(3-4):309-34. PubMed ID: 3235687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreases in apolipoprotein(a) after renal transplantation: implications for lipoprotein(a) metabolism.
    Black IW; Wilcken DE
    Clin Chem; 1992 Mar; 38(3):353-7. PubMed ID: 1547551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormal concentrations of CII, CIII, and E apolipoproteins among apolipoprotein B-containing, B-free, and A-I-containing lipoprotein particles in hemodialysis patients.
    Alsayed N; Rebourcet R
    Clin Chem; 1991 Mar; 37(3):387-93. PubMed ID: 2004445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indirect sandwich enzyme-linked immunosorbent assay (ELISA) for plasma apolipoprotein E.
    Kee P; Bais R; Sobecki SK; Branford S; Rye KA; Barter PJ
    Ann Clin Biochem; 1996 Mar; 33 ( Pt 2)():119-26. PubMed ID: 8729719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantification of human serum apolipoprotein AI by enzyme immunoassay.
    Bury J; Rosseneu M
    Clin Chem; 1985 Feb; 31(2):247-51. PubMed ID: 3917876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tangier disease: defective recombination of a specific Tangier apolipoprotein A-I isoform (pro-apo A-i) with high density lipoproteins.
    Schmitz G; Assmann G; Rall SC; Mahley RW
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6081-5. PubMed ID: 6412234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women.
    Brinton EA; Eisenberg S; Breslow JL
    J Clin Invest; 1989 Jul; 84(1):262-9. PubMed ID: 2500457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary apo(a) discriminates coronary artery disease patients from controls.
    Kostner KM; Huber K; Stefenelli T; Rinner H; Maurer G
    Atherosclerosis; 1997 Feb; 129(1):103-10. PubMed ID: 9069524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein and lipid composition of plasma lipoproteins in neonates during the first month of life.
    van Biervliet JP; Rosseneu M; Bury J; Caster H; Stul MS; Lamote R
    Pediatr Res; 1986 Apr; 20(4):324-8. PubMed ID: 3085061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.